The CPAP mask supply chain and the mask-selection clinical workflow in Australia have stabilised through 2024 and into 2026 after the shortages of 2021–2022. Worth a working read of where the supply and the clinical practice sit in May 2026.

The supply picture.

The major mask manufacturers — ResMed, Philips, Fisher & Paykel, and a smaller cohort of secondary brands — are running at stable production capacity. The supply chain disruptions of the post-pandemic period have resolved. The wait time for any common mask configuration in Australia is back to the historical normal — typically same-week or next-week availability from the main supplier networks.

The product line refresh cycle has continued. The recent refreshes across the major manufacturers have produced incremental improvements in comfort, materials, and headgear design rather than dramatic redesigns. The major mask categories — full face, nasal, and nasal pillow — have all seen iterative product improvements through the period.

The Philips replacement program from the foam-related notice of earlier years has worked through. The patient remediation pathways are mature at this stage. The clinical practice has adapted.

The mask selection clinical workflow.

The mask selection process for a new CPAP patient remains one of the most consequential interventions for long-term therapy adherence. The clinical workflow has been refined through years of adherence data and now follows a fairly consistent pattern at most Australian sleep clinics.

The initial fitting session ideally happens with a trained sleep clinician or therapist who has hands-on familiarity with the major mask options. The patient is fitted with several candidate masks across the categories before settling on the initial choice. The discussion covers nasal breathing versus mouth breathing patterns, facial structure considerations, sleep position preferences, claustrophobia tolerance, and the patient’s overall comfort during the fitting.

The trial period for the initial mask is typically two to four weeks. The clinic remains in contact with the patient during this period and adjusts the mask if the initial choice is not working. The willingness to change the mask early is one of the most important predictors of long-term adherence. The patient who is forced to persist with an uncomfortable mask is the patient who abandons therapy within months.

The pressure trial alongside the mask selection is part of the workflow. The combination of an inappropriate mask and an inadequately-titrated pressure is the most common reason for early therapy abandonment. The clinics that integrate mask and pressure adjustment well in the first month have meaningfully better long-term adherence rates than the clinics that do not.

The mask replacement cadence.

The mask cushion replacement cadence for most CPAP patients is one to three months depending on cushion type. The frame and headgear replacement cadence is six to twelve months. The full mask replacement cadence is typically twelve to twenty-four months.

The patient adherence to the replacement cadence is poor across the patient population. The clinics that have built reminder systems and have arrangements with their supplier to ship replacement parts on a subscription basis have meaningfully better mask-condition outcomes than the clinics that rely on patient-initiated replacement orders.

The funding picture for replacements continues to be the most-asked question at the clinic. The private health fund cover for CPAP consumables varies across funds and across policy types. The MBS does not directly cover CPAP consumables. The patient out-of-pocket cost for mask replacements remains a meaningful financial consideration over the long-term therapy horizon.

Common selection considerations.

For new patients with predominantly nasal breathing during sleep, a nasal mask or nasal pillow system is usually the first choice. The smaller interface, the lower bulk during sleep, and the easier tolerance for active sleepers are the typical advantages.

For new patients with mouth breathing during sleep — either habitual or pressure-induced — a full face mask is usually needed. The trade-off is the larger interface and the higher leak potential.

For patients with significant facial hair, the mask selection requires extra care. The seal across a beard is a meaningful adherence consideration and several manufacturers have specific products designed for this population.

For patients with claustrophobia tendencies, the smallest possible interface is usually the better starting point. The nasal pillow systems are often well-tolerated by patients who would not tolerate a full face mask.

For patients with high pressure requirements, the seal performance and the leak management become more important. The mask choice and the pressure ramp settings need to be considered together.

A few practical observations from clinical work in May 2026.

The patient education at fitting has continued to improve. The clinic that takes the time to teach the patient about cleaning, replacement, troubleshooting common issues, and the role of the mask in the broader therapy gets better adherence outcomes than the clinic that hands over the kit with minimal instruction.

The remote monitoring data from the CPAP devices has been useful in early identification of mask issues. The leak data on the device download often surfaces a mask problem before the patient calls the clinic. The clinics that review the remote data regularly are intervening earlier and saving therapy adherence at the margin.

The telehealth follow-up has been useful for routine mask check-ins. The complex mask adjustments still need in-person sessions but the routine adherence check-ins work well over video.

The Australian CPAP mask supply and the clinical practice around it are in a mature, stable state in May 2026. The supply is reliable, the products are incrementally better than they were five years ago, and the clinical workflow has been refined through decades of adherence data. The patient who is fitted properly and supported through the first months of therapy has a high probability of being on therapy ten years later. The patient who is poorly fitted is at risk of abandoning therapy entirely. The investment in getting the mask selection right is the highest-impact intervention in CPAP care.